What is Palvella Therapeutics's AOCI?

Palvella Therapeutics (PVLA) reported AOCI of $95K in Q1 2026.

How has Palvella Therapeutics's AOCI changed year-over-year?

Palvella Therapeutics's AOCI increased by 3266.7% year-over-year, from -$3K to $95K.

What is the long-term trend for Palvella Therapeutics's AOCI?

Over 5 years (2020 to 2025), Palvella Therapeutics's AOCI has grown at a -22.4% compound annual growth rate (CAGR), from -$295K to $83K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Palvella Therapeutics PVLA AOCI

AOCI at other companies

Relay Therapeutics, Inc.RLAY

-$172K-553%

Viridian Therapeutics, Inc.VRDN

-$558K-328%

ANI PharmaceuticalsANIP

$479K-86.7%

PrecigenPGEN

-$17K-242%

Arcutis Biotherapeutics, Inc.ARQT

-$514K-267%

Ultragenyx PharmaceuticalRARE

$0+100%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's AOCI?: Palvella Therapeutics (PVLA) reported AOCI of $95K in Q1 2026.
How has Palvella Therapeutics's AOCI changed year-over-year?: Palvella Therapeutics's AOCI increased by 3266.7% year-over-year, from -$3K to $95K.
What is the long-term trend for Palvella Therapeutics's AOCI?: Over 5 years (2020 to 2025), Palvella Therapeutics's AOCI has grown at a -22.4% compound annual growth rate (CAGR), from -$295K to $83K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.